AI-generated summary
The authors used adaptive optics scanning laser ophthalmoscopy to compare cone photoreceptor structure and retinal microvasculature in myopic children receiving repeated low-level red light therapy, untreated myopic children, and non-myopic children. They report no significant loss of cone density or microvascular change after at least 8 months of treatment, and lower cone dispersion in the treated group. The cross-sectional design and small group sizes limit conclusions about long-term safety.
- Who or what was studied
- Children with myopia who received repeated low-level red light therapy (20 eyes), myopic children who were untreated (32 eyes), and non-myopic children (14 eyes)
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The study is cross-sectional with small group sizes and does not establish long-term safety or causality.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Purpose
Despite the growing use of repeated low-level red light (RLRL) therapy for myopic children, its safety remains controversial. This study aimed to analyze macular cone morphology and retinal microvascular hemodynamics using adaptive optics scanning laser ophthalmoscopy (AOSLO) to evaluate retinal microstructural impacts.
Design
Cross-sectional study.
Methods
Three groups were recruited: Myopia-RLRL (20 eyes; ≥8 months treatment), Myopia-Untreated (32 eyes), and Non-Myopic (14 eyes). RLRL therapy was administered using a 650 nm laser at 0.29 mW, twice daily for 3 min per session. AOSLO was used to assess cone morphology (density, spacing, regularity, dispersion) and retinal microvasculature parameters (vessel diameter, lumen diameter, blood flow velocity).
Results
Cone density was higher in the Non-Myopic group (45,649 ± 5092/mm²) compared to the Myopia-Untreated group (40,202 ± 7365/mm², P = 0.013), with no significant difference versus the Myopia-RLRL group (41,274 ± 6228/mm², P = 0.627). Cone spacing was enlarged in myopic groups relative to non-myopic (P < 0.05). Cone dispersion was lower in the Myopia-RLRL group (16.47 ± 2.43%) than in the Myopia-Untreated (17.36 ± 2.14%, P = 0.030) and Non-Myopic (17.80 ± 2.25%, P = 0.024) groups. No significant intergroup differences were found in cone regularity or microvasculature. Cone density positively correlated with spherical equivalent refraction (r = 0.541) and negatively with axial length (r=-0.594; both P < 0.001).
Conclusions
After 8 months of RLRL therapy, there was no significant loss of cone density or issues with retinal microvasculature. Assessment of retinal arteriole and venule diameters and flow velocity also showed no significant differences. The reduced cone dispersion in the RLRL group suggests potential photobiomodulation effects on photoreceptor organization, indicating the therapy's safety and potential benefits.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
- Power
- 0.29 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Laser, Red light therapy, Photobiomodulation, Photoreceptor. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.